Skip to Content

SANKYO C22 (Hydrochlorothiazide and Olmesartan Medoxomil 12.5 mg / 20 mg)

Pill with imprint SANKYO C22 is Yellow, Round and has been identified as Hydrochlorothiazide and Olmesartan Medoxomil 12.5 mg / 20 mg. It is supplied by Sun Pharmaceutical Industries Inc..

Hydrochlorothiazide/olmesartan is used in the treatment of high blood pressure and belongs to the drug class angiotensin II inhibitors with thiazides. There is positive evidence of human fetal risk during pregnancy. Hydrochlorothiazide/olmesartan 12.5 mg / 20 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for SANKYO C22

Hydrochlorothiazide and olmesartan medoxomil 12.5 mg / 20 mg SANKYO C22 Front
Hydrochlorothiazide and olmesartan medoxomil 12.5 mg / 20 mg SANKYO C22 Back

Hydrochlorothiazide and Olmesartan Medoxomil

Imprint
SANKYO C22
Strength
12.5 mg / 20 mg
Color
Yellow
Size
9.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Angiotensin ii inhibitors with thiazides
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Sun Pharmaceutical Industries Inc.

Labelers / Repackagers

NDC Code Labeler / Repackager
57664-0758 Caraco Pharmaceutical Laboratories, Ltd.
65597-0105 Daiichi Sankyo
54868-5170 Physicians Total Care Inc. (repackager)
35356-0256 Lake Erie Medical and Surgical Supply (repackager)

Get help with Imprint Code FAQs.

Related Images for "SANKYO C22"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.